Tolerability and Steady-state Pharmacokinetics of BIA 6-512

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
To investigate the tolerability and safety of four multiple-dose regimens of BIA 6-512 (25 mg, 50 mg, 100 mg, and 150 mg 6 times daily) in healthy volunteers and to characterise the steady-state pharmacokinetic profiles of BIA 6-512 (25 mg, 50 mg, 100 mg, and 150 mg 6 times daily) in healthy volunteers.
Epistemonikos ID: df710673dd11c722b9f91d94b579fe189f9bc814
First added on: May 20, 2024